TMEM165 Gene Glycosylation disorder type 2K Genetic Test
Welcome to DNA Labs UAE, where we offer the TMEM165 Gene Glycosylation disorder type 2K Genetic Test. This test helps diagnose Congenital Disorder of Glycosylation Type 2K (CDG2K), a rare genetic disorder affecting the glycosylation process in the body.
Test Details
The TMEM165 gene is associated with CDG2K, a genetic disorder that affects the attachment of sugar molecules to proteins and lipids in the body. Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, including the TMEM165 gene, to identify any genetic variations or mutations causing the glycosylation disorder.
Test Components and Price
The TMEM165 Gene Glycosylation disorder type 2K Genetic Test is priced at 4400.0 AED. The test requires a blood or extracted DNA sample, or one drop of blood on an FTA card.
Report Delivery
Once the sample is collected, the report will be delivered within 3 to 4 weeks.
Test Type and Method
The TMEM165 Gene Glycosylation disorder type 2K Genetic Test falls under the category of Metabolic Disorders. We utilize NGS technology to analyze the DNA sequence and identify any genetic variations or mutations in the TMEM165 gene.
Referring Doctor and Test Department
The referring doctor for this test is a General Physician. The test is conducted in our Genetics department.
Pre Test Information
Prior to the TMEM165 Gene Glycosylation disorder type 2K Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by Glycosylation disorder type 2K.
Understanding CDG2K
CDG2K is a rare genetic disorder that affects the glycosylation process. The TMEM165 gene provides instructions for producing a protein involved in sugar molecule transport within cells. Mutations in this gene can cause the glycosylation disorder, leading to various symptoms and complications.
NGS Genetic Testing Process
The NGS genetic test for TMEM165 gene mutations involves collecting a DNA sample, usually through blood or saliva. The DNA is then sequenced to identify any variations or mutations in the gene. These results help healthcare professionals understand the underlying cause of the glycosylation disorder and guide treatment and management strategies for individuals with CDG2K.
At DNA Labs UAE, we are dedicated to providing accurate and reliable genetic testing services. If you suspect CDG2K or have any concerns about glycosylation disorders, consult with our expert team and get the TMEM165 Gene Glycosylation disorder type 2K Genetic Test today.
| Test Name | TMEM165 Gene Glycosylation disorder type 2K Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TMEM165 Gene Glycosylation disorder type 2K NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2K |
| Test Details |
The TMEM165 gene is associated with a glycosylation disorder called Congenital Disorder of Glycosylation Type 2K (CDG2K). CDG2K is a rare genetic disorder that affects the glycosylation process, which is the attachment of sugar molecules to proteins and lipids in the body. This gene is responsible for providing instructions for the production of a protein that is involved in the transport of sugar molecules within cells. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze a person’s DNA sequence. It allows for the simultaneous analysis of multiple genes, including the TMEM165 gene, to identify any genetic variations or mutations that may be causing the glycosylation disorder. This type of genetic testing can help confirm a diagnosis of CDG2K and provide information about the specific genetic variant causing the disorder. The NGS genetic test for TMEM165 gene mutations typically involves collecting a DNA sample, usually through a blood or saliva sample, and sequencing the DNA to identify any variations or mutations in the gene. The results of the test can help healthcare professionals better understand the underlying cause of the glycosylation disorder and may inform treatment options and management strategies for individuals with CDG2K. |
